US loss of exclusivity · Other

Reblozyl

Bristol Myers Squibb

2031US biosimilars from
2025Today: 20262037
2025 worldwide sales
$2.3B
Date basis
Company guidance
US biosimilars
No US filing found
Pharma Patent Cliff by readouts.io Data checked 8 October 2026 · Full Reblozyl timeline →